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ABSTRACT
THE EFFECT OF POST-EXERCISE MEAL COMPOSITION ON INSULIN ACTION
SEPTEMBER 2007
KAILA A. HOLTZ
B.S., UNIVERSITY OF MASSACHUSETTS AMHERST
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Barry Braun
INTRODUCTION: Exercise increases insulin stimulated glucose uptake (insulin
action) if expended energy (kcal) is withheld following exercise, but the effect is
blunted when expended energy is replaced as carbohydrate. Restricting carbohydrate
and replacing expended energy as fat maintains increased insulin action in rodents;
however, this effect has not been evaluated in humans. In humans, restricting
carbohydrate intake following exercise may be a useful strategy to maximize the effect
of individual exercise bouts on insulin action and promote gains in metabolic health
over time. Therefore, the purpose of this study was to determine if carbohydrate
restriction following exercise (carbohydrate deficit) increased insulin action in
sedentary, overweight adults as hypothesized. METHODS: Ten healthy, sedentary,
men and women, aged 21±2 years, body fat 37.3±3.1%, and VO2peak 34.6±1.2ml×kg1

×min-1 completed three, two-day experimental conditions in random order: 1) a no-

exercise baseline condition (BASE), 2) exercise followed by a high-carbohydrate meal
(HIGH-CHO= 76.3±2.5% CHO), and 3) exercise followed by a low-carbohydrate meal
(LOW-CHO=17.8±0.1% CHO). On DAY 1, subjects came to the laboratory (early
evening) and expended 30% of total daily energy expenditure on a cycle ergometer at
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70% of VO2peak. Following exercise, an isocaloric meal (HIGH-CHO or LOW-CHO)
was consumed to refeed the expended energy during exercise and venous blood samples
were taken to record the insulin and glucose responses to the meals. Twelve hours later
(Day 2), whole-body insulin action (steady-state glucose uptake per unit insulin) was
measured using a continuous infusion of glucose with stable isotope tracers. A paired ttest was used to detect differences between exercise bouts and the glucose and insulin
responses to the post-exercise meals. A one-way repeated measures ANOVA was
performed to evaluate the effect of experimental condition on insulin action (p<0.05, for
all tests). RESULTS: Intensity (VO2peak), duration (minutes) and energy expenditure
(kcal) were similar between exercise bouts. After exercise, plasma glucose and insulin
concentrations were significantly higher following the HIGH-CHO meal compared to
the LOW-CHO meal (p<0.001, respectively). The next morning, insulin action was
similar between experimental conditions (p=0.30). Non-oxidative glucose disposal was
increased during the glucose infusion in Low-CHO compared to BASE (27.2±3.2 vs.
16.9±3.5µM×kg-1×min-1, p<0.05). Carbohydrate oxidation was reduced in Low-CHO
(8.6±1.3µM×kg-1×min-1) compared to High-CHO (12.2±1.2µM×kg-1×min-1), and to
BASE (17.1 ± 2.2 µM×kg-1×min-1), p<0.05 respectively. Resting fat oxidation was
increased in Low-CHO compared to BASE (109.8 ± 10.5 mg×min-1 vs. 80.7 ± 9.6
mg×min-1, p<0.05) and remained elevated during the glucose infusion.
CONCLUSION: Limiting carbohydrate, but not energy intake after exercise
(carbohydrate deficit) resulted in increased non-oxidative glucose disposal, decreased
carbohydrate oxidation and increased fat oxidation during the glucose infusion,
compared to baseline, indicating a favorable shift in energy metabolism. Creating a
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carbohydrate deficit, by withholding expended carbohydrate but not energy following
exercise may be a sensible strategy to promote favorable gains in insulin action that
requires further evaluation.
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CHAPTER 1
DEVELOPMENT OF THE PROBLEM

1.1 Introduction
Type 2 diabetes is preceded by insulin resistance, a condition that is
characterized by decreased insulin action (37). Insulin action is defined by the effectivity
of insulin to stimulate peripheral glucose uptake from the blood, decrease whole body
lipolysis of adipose tissue, and suppress hepatic glucose output. Regular physical
activity increases insulin action and slows the progression from insulin resistance to
type 2 diabetes (41).
An acute bout of exercise increases insulin action (3, 7, 18, 51, 57). Creating an
energy deficit through caloric restriction also increases insulin action (2). Following
exercise, the nutritional environment created by energy intake, or lack of energy intake,
affects the degree insulin action is increased. Combining exercise with an energy deficit
(not replacing expended energy after exercise) significantly increases insulin action.
This effect is not observed when energy is re-fed as dietary carbohydrate to energy
balance (energy expenditure = energy balance) (5, 54).
When dietary carbohydrate is restricted after exercise in rodents, insulin action
remains elevated until carbohydrate is re-fed (11, 21). The mechanism relating
carbohydrate restriction to increased insulin action following exercise is poorly
understood but may be a function of maintaining low glycogen concentrations by
inadequate carbohydrate intake (12). Low muscle glycogen regulates enzymatic activity

1

that promotes glycogen storage (16, 35, 39) which is associated with increased insulin
action (50).
Carbohydrate restriction in rodents can be accomplished in two ways. Either
expended energy is withheld following exercise (creating both energy and carbohydrate
deficits), or energy is re-fed without carbohydrate (creating a carbohydrate deficit only).
It has been well established that restricting carbohydrate and refeeding expended energy
as fat maintains increased insulin action in rodents (11, 21). However, this effect has not
been systematically evaluated in humans. Maximizing the effectiveness of every
exercise bout could result in the greatest long-term gains in metabolic health.

Summary: An energy deficit after exercise clearly increases insulin action. It remains
unclear if refeeding expended energy, but not carbohydrate to a carbohydrate deficit,
affects insulin action compared to the match of carbohydrate expenditure with intake
(carbohydrate balance). Therefore, the purpose of this study is to evaluate the effect of
carbohydrate availability following exercise on insulin action.

1.2 Statement of the Problem
Energy intake following acute exercise affects insulin action in ways that are
poorly understood. Regular exercise is a viable way for sedentary, overweight
individuals with impaired insulin action to improve their metabolic health though the
nutritional environment following exercise may moderate its effect. Fasting after
exercise increases insulin action, yet individuals most often eat soon after an exercise
session. It has been demonstrated that re-feeding expended energy after exercise as
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dietary carbohydrate eliminates exercise-induced increases in insulin action (5, 7, 58). It
is unclear whether energy or carbohydrate moderates enhanced insulin action reversal
following a post-exercise meal high in carbohydrate. Evidence for restricting
carbohydrate and replacing expended energy with fat (to maximize the effectiveness of
exercise on insulin action) appears strong in animal models (11, 21), but conclusions
from animal models are limited and need to be evaluated systematically before being
applied to humans.

1.3 Purpose and Hypotheses
The purpose of this study is to evaluate how varying carbohydrate availability
after exercise affects insulin action in sedentary, overweight adults. A strong
relationship between post-exercise carbohydrate availability and insulin action is
expected. Increases in insulin action will be largest when post-exercise carbohydrate
availability is low and smallest following high post-exercise carbohydrate availability.
It is hypothesized: 1) high carbohydrate availability following an acute bout of
exercise will nullify the sensitizing effect of exercise on insulin action and return insulin
action toward baseline, and 2) low carbohydrate availability following exercise will
significantly increase insulin action compared to both baseline, and a condition of highcarbohydrate availability.

1.4 Significance of the Study
Athletes increase carbohydrate intake immediately after exercise in order to
maximize glycogen re-synthesis and optimize performance (29). However, low

3

glycogen concentrations are associated with increased insulin action (17, 50);
individuals with impaired insulin action might benefit from minimizing post-exercise
carbohydrate intake. In addition, low carbohydrate availability maintains increased
activity of oxidative enzymes compared to high carbohydrate availability (48).
Maintaining the activity of oxidative enzymes may be important for the accrual of
exercise benefits on metabolic health. Identifying ways to combine exercise and diet to
maximize increases in insulin action will benefit individuals at risk for type 2 diabetes.

1.5 Limitation
Conclusions from this study will be limited to the effect of post-exercise
carbohydrate availability on insulin action at the whole body level. While experimental
conditions may yield muscle and liver glycogen concentrations that vary, it is
impossible to relate changes in muscle glycogen concentrations and cellular regulators
to changes in insulin action without muscle biopsies. Insight regarding the molecular
mechanisms underlying the regulation of insulin action by carbohydrate availability on
insulin action will be speculative; however, it is expected that results from this study
will provide new information regarding the mediation of whole body insulin action by
carbohydrate availability following exercise.

1.6 Definition of Terms
Carbohydrate availability: the amount (g) of digestible carbohydrate in a meal.
Carbohydrate deficit: the difference between carbohydrate expended during exercise
(g) and carbohydrate consumed after exercise (g).
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Carbohydrate balance: carbohydrate expenditure during exercise matched with
carbohydrate intake after exercise.
Energy balance: a period when energy intake (kcal) equals energy expenditure (kcal).
Energy deficit: a period when energy expenditure (kcal) exceeds energy intake (kcal).
Insulin action: the effectivity of insulin to stimulate peripheral glucose uptake in
insulin responsive tissues (skeletal muscle, the liver and adipose tissue).
Insulin resistance: a condition of reduced glucose uptake in response to physiological
insulin that precedes the development of type 2 diabetes.
Metabolic health: the combined markers (insulin action, fat oxidation and plasma
lipids) measured in this study.

5

CHAPTER 2
UPDATED LITERATURE REVIEW

2.1 Introduction
Approximately 8% of the adult population in the United States is diagnosed with
type 2 diabetes (27, 45). Increasing incidence of type 2 diabetes parallels increasing
incidence rates of obesity (45)since impaired insulin action and obesity share a common
origin (49): a family history of type 2 diabetes (25) combined with a sedentary lifestyle
(42).
The Diabetes Prevention Program (DPP) demonstrated that lifestyle
interventions increase physical activity and decrease energy intake and significantly
reduce the risk of type 2 diabetes (41). The results of the DPP and others (55) suggest
that exercise be viewed as a “drug” for metabolic health. As defined in the Food and
Drugs Act, a drug includes “any substances for use in the diagnosis, cure, mitigation,
treatment, or prevention of disease intended to affect the structure or any function of the
body”. Exercise fits this description of a drug because it affects cellular structure and
function, and has been associated with the prevention or treatment of cardiovascular
disease (19), osteoporosis (15), mental dysfunction (32), and type 2 diabetes (41, 55).
Like pharmacological drugs, exercise interacts with the nutritional environment
proximate to its application. Exercise increases insulin action, but the nutritional
environment following an exercise session may influence the magnitude of this effect.
There is evidence to suggest that any benefit of exercise on insulin action in sedentary,
overweight individuals with impaired insulin action may be reversed by carbohydrate
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consumed after exercise completion (5, 7). Thus, research to find sensible exercise and
diet prescriptions for a sedentary, overweight population is necessary to maximize the
positive effect of each exercise dose and minimize the negative interactions between
exercise and certain nutritional prescriptions.
Maximizing the effect of a single exercise dose is important for two reasons.
First, habitually sedentary individuals may exercise sporadically as they contemplate
beginning an exercise program; sensible nutritional prescriptions are necessary to ensure
benefits are not reversed by nutritional choices. Second, exercise results are most
favorable when repeated over time through applications of individuals exercise sessions;
if each exercise dose is maximized (by nutritional prescriptions) the cumulative effect of
exercise on metabolic health may be greatest.

2.2 Current Exercise and Diet Prescriptions
A growing population of sedentary, overweight/obese individuals with poor
metabolic health has prompted several national health bodies (ACSM, IOM, CDC) to
announce exercise prescriptions for weight loss and health improvement. The duration
and intensity of exercise required to elicit weight loss and/or increase metabolic health
remains controversial; however, it is agreed that exercise (regardless of duration) is
better than no exercise at all (6). While more sedentary overweight Americans may be
starting exercise programs, these exercise prescriptions do not have a specific diet
component as recommendations for athletes do.
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2.2.1 Athletes
Research in the late 1970’s and early 1980’s first demonstrated the importance
of carbohydrate intake during and following endurance exercise to maximize
performance (9, 12, 34). Consuming high-glycemic dietary carbohydrate following
exercise quickly increases blood glucose and insulin concentrations and replenishes
muscle glycogen (9). Athletes do this because high levels of muscle glycogen are
associated with increased exercise performance (29). Research in the area of postexercise nutrition has largely focused on generating recommendations to promote
glycogen re-synthesis in athletes, agreed upon to be 5-7g/kg body weight/day during
moderate training (36).

2.2.2 Sedentary, Overweight Individuals
Sedentary, overweight individuals have different metabolic profiles than
physically active, lean individuals (athletes). Two markers of poor metabolic health are:
impaired insulin action (23) and decreased fat oxidation (40), both of which can be
improved with exercise (8, 14). In contrast to athletes, the post-exercise dietary
recommendations for overweight, sedentary individuals are not nutrient specific.
Generally, the 2005 Dietary Guidelines for Americans state: “Control of caloric intake is
advisable (for overweight/obese individuals) ... The higher a person's physical activity
level, the higher his or her energy requirement.” Given the rising levels of obesity in the
United States, current recommendations understandably promote exercise and diet as a
means to regulate body weight. However, the benefits of exercise on metabolic health
are apparent before changes in body weight occur (1, 5). Moreover, increased metabolic
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health is observed regardless of body composition when cardiorespiratory fitness is
matched (22) (overweight individuals are as “metabolically healthy” as lean individuals
when they are aerobically fit). Maximizing the effect of exercise on metabolic health
with nutritional recommendations following exercise may be as important, if not more
so, than promoting weight loss.

Summary: Current exercise and diet prescriptions for the sedentary, overweight
population are general and do not include specific strategies to maximize the effect of
each exercise session on metabolic health. This population may not benefit from
following the same exercise and diet prescription given to athletes – because their
metabolic profile is different and their goals should be to improve metabolic health and
reduce the risk of disease, not to maximize endurance performance.

2.3 Exercise and Insulin Action
One exercise session increases insulin action compared to baseline in both lean
fit (7, 30, 51) and overweight sedentary (3, 10, 18, 28, 57) individuals. There are two
signaling pathways of glucose uptake: the insulin-stimulated pathway and the
contraction-mediated (exercise) pathway. Following exercise the pathways interact to
stimulate glucose uptake in a manner greater than the sum of the two pathways working
independently (13). Moreover, increased insulin-stimulated glucose uptake (following
exercise) results largely from one exercise bout and is not an adaptation to exercise
training (31, 51). Individuals with impaired insulin action may therefore seek to
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immediately target the contraction-mediated pathway of skeletal muscle glucose uptake
to overcome their reduced ability to stimulate it with insulin (24).

2.4 Interaction between Exercise and Diet to Influence Insulin Action

2.4.1 Effect of Energy Intake Following Exercise
Recently, the Energy Metabolism Laboratory at the University of Massachusetts
paired an energy deficit with exercise to evaluate its combined effect on insulin action.
To test the hypothesis that manipulating energy balance following exercise affects
insulin action, Black et al. separated sedentary, overweight subjects into two groups: an
exercise-induced energy deficit group (DEF) and an energy balance group (BAL) (5).
The BAL group was re-fed expended energy during and immediately after exercise over
a 6 day period; the DEF group was not re-fed any energy after exercise. Insulin action
was not increased in the BAL group (compared to baseline); however, the DEF group
(having an energy deficit of -481 kcal), increased insulin action by 40% (compared to
baseline).
The finding from Black et al. – that restoring energy balance by re-feeding
expended energy reverses increased insulin action toward baseline – confirmed findings
of longer term training studies (52, 54). Ross et al. in a study matching energy
expenditure with intake maintained a stable body mass and demonstrated no
improvement in insulin action after 14 weeks of exercise training (52). Similarly, Segal
et al, during 12 weeks of training, added a carbohydrate supplement to subjects’ diets
equivalent to the amount of expended energy due to exercise. Segal et al. subjects
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successfully maintained body weight and saw no increase in insulin action following
exercise training (54).
The results of Black et al. and longer exercise training studies suggest that
creating an energy deficit after exercise is necessary to improve insulin action. However,
two factors that may influence insulin action were not controlled in the Black, Segal and
Ross studies. First, expended energy was re-fed immediately during, and after exercise;
meal timing may influence post-exercise insulin action (33) and this will not be
addressed by this study. Second, post-exercise meals were composed mainly of highglycemic carbohydrate; consuming high-glycemic carbohydrate following exercise
affects insulin action (5, 7). Evaluating the effect of varying post-exercise carbohydrate
intake on insulin action is the focus of this study.

2.4.2 The Effect of Dietary Carbohydrate Intake Following Exercise
Carbohydrate feeding following intense exercise reverses insulin action toward
baseline (5, 7, 11, 21, 58). It was first demonstrated in rodents (11, 21, 58); in humans,
Bogardus et al. also demonstrated a reversal of increased insulin action after exercise
with carbohydrate feeding (7). Bogardus et al. exercised subjects and afterwards they
were fasted or fed 100 grams of carbohydrate. The 100g of carbohydrate did not replace
all of the expended energy but blunted the effect of exercise (to increase insulin action).
This finding suggests that carbohydrate intake following exercise affects insulin action,
independent of energy deficit, in a manner that requires further exploration.

11

2.4.2.1 Potential Mechanism
The majority of carbohydrate consumed after exercise is stored as muscle
glycogen (9). Insulin action and muscle glycogen have a poorly understood inverse
relationship (50), but low muscle glycogen correlates well with increased insulin action
(16). Mechanistically, glucose transporters (GLUT4), glycogen synthase activity and
AMPK activity are all high after exercise, and all contribute to increased insulin action
when muscle glycogen concentrations are low (56). When muscle glycogen is supercompensated, insulin action is attenuated (21, 39). Kawanaka et al. found glycogen
super-compensation resulted in a significant reduction in GLUT4 concentrations at the
muscle cell membrane (compared to baseline), a reduction in PKB phosphorylation
(involved in the pathway of insulin signaling and glycogen synthesis) and a reduction of
AMP kinase (an energy sensing kinase also involved in insulin signaling and glucose
uptake) (39). They suggested a negative feedback mechanism by which an influx of
glucose into the muscle cell, after the absorption of carbohydrate, affects cellular
metabolism to down-regulate further glycogen synthesis. A follow-up study revealed
glycogen may be one contributing factor, but not solely responsible for moderating
insulin action (38); it has been suggested that the molecular regulation of insulin action
by carbohydrate intake may depend also on the insulin response to carbohydrate intake
before glycogen can be synthesized (48).

2.4.3 The Effect of Fat Intake Following Exercise
In rodents, restricting carbohydrate intake after exercise by increasing fat intake
prolongs increased insulin action (11, 21). To obtain information regarding the length of
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time this effect persists, Cartee et al. (11), exercised and separated the animals into one
of four meal conditions: standard chow (60% carbohydrate), lard (100% fat), 50/50
corn-starch and glucose (100% carbohydrate), and a control (fasted). Insulin action was
reversed toward baseline within 18 hours in the carbohydrate fed group but remained
significantly increased in the fat-fed group for 48 hours following the cessation of
exercise. Similar results were produced by Garcia-Roves et al., who evaluated the
hypothesis that skeletal muscle maintains its capacity to promote glycogen synthesis as
long as glycogen super-compensation is prevented. Again, insulin action remained
elevated as long as muscle glycogen levels were kept low by fasting or fat-feeding. Thus
(in rodents) a carbohydrate deficit by restricting carbohydrate intake after exercise may
increase insulin action as effectively as an energy deficit.
Human studies evaluating the effect of post-exercise fat feeding on insulin action
also supports that fat intake does not decrease insulin action. Schenk et al. (53),
following exercise, infused a lipid and heparin solution overnight which created an
energy surplus of ~1100 fat calories. Insulin action the next morning was similar to the
control condition of a post-exercise saline infusion. In another study by the same
research group, Fox et al. fed subjects a high-fat vs. a low-fat diet following exercise, of
equal carbohydrate content (~350 grams), and demonstrated similar insulin action the
next morning between conditions (20). Moreover, the high-fat condition restored 24
hour energy balance, while the low-fat condition created an energy deficit of ~
1500kcals which did not affect insulin action (both groups had similar insulin action).

13

Summary: Rodent data demonstrates that exercise-induced increases in insulin action
were prolonged with fat intake. Both the Schenk and Fox studies, conducted in humans,
demonstrated that insulin action following exercise was not negatively affected by fat
intake but carbohydrate was not restricted in those studies. It remains unclear though,
how of post-exercise carbohydrate restriction combined with increased fat intake may be
a useful nutritional strategy to maximize insulin action in humans.

2.5 Methodologies for Metabolic Measurements

2.5.1 Measures of Insulin Action
In response to increased glucose concentrations in the plasma, an insulin release
is triggered by the islet cells of the pancreas to clear glucose into peripheral tissues,
inhibit lipolysis and decrease hepatic glucose production. Measurements of the
effectivity of insulin to stimulate glucose uptake fall into two categories: the open loop
and closed loop approaches (4). The open loop approach breaks the feedback
mechanism between glucose concentrations and the pancreas by infusing glucose and
insulin to euglycemic and hyperinsulinemic conditions. An advantage of the open-loop
approach is its sensitivity and tissue specificity – the hyperinsulinemic, euglycemic
clamp is the gold standard measure of insulin action in research. A disadvantage of the
open loop approach is that the physiological conditions during insulin action’s
measurement do not simulate “real-world” scenarios. During the hyperinsulinemic,
euglycemic clamp, specifically, insulin concentrations remain artificially elevated
throughout the entire 2 – 4 hour measurement, while glucose is infused intravenously to
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match increased glucose uptake in response to the heightened insulin concentrations.
The clamp is in direct contrast to a “real-world” scenario where carbohydrate is ingested
and blood glucose/ insulin concentrations increase, then decrease over time.
The closed loop approach does not disrupt the feedback mechanism between
glucose concentrations and the pancreas. For example, the oral glucose tolerance test
(OGTT) of insulin action is a closed loop test; a glucose challenge of 75g is ingested
within 5 minutes and blood glucose/ insulin concentrations are sampled every 30
minutes over the next two hours. From the glucose/ insulin concentrations, an area
under the curve (AUC) is generated. In response to an intervention, if the AUC of both
glucose and insulin increase, insulin action has decreased. Conversely, if the AUC for
both glucose and insulin decreases, insulin action has increased.
Compared to the clamp, advantages of this measure are: the cost of an OGTT is
significantly less in terms of resources and time, and using the C-ISI index (proposed by
Matsuda and DeFronzo) is a measure of insulin action that correlates well with clamp
values (43). A disadvantage of the OGTT, compared to the clamp, is that sensitivity and
tissue specificity may be lost. An OGTT assesses whole body insulin action, while the
clamp (especially if stable isotopes are included in the glucose infusate) allows
researchers to make inferences about the rate of glucose disposal, storage, oxidation and
hepatic glucose production.

2.5.2 Continuous Infusion of Glucose with Stable Isotope Tracers
The continuous infusion of glucose with stable isotope tracers (CIG-SIT)
evaluates insulin action by combining the open and closed loop approaches was
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developed by the Energy Metabolism Laboratory at the University of Massachusetts and
has been used successfully (5). Glucose is infused to stimulate plasma glucose/ insulin
concentrations similar to a mixed meal (“real world” scenario) while allowing
researchers to measure non-oxidative glucose disposal, oxidation and hepatic glucose
production (tissue specific). Insulin action values generated during the CIG-SIT
correlate well with the OGTT (r=0.78, p<0.001) meaning the test accurately assesses
insulin action relative to other known measures.
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CHAPTER 3
METHODS

3.1 Proposed Study Design
To test the hypothesis that post-exercise meal composition affects insulin action,
it was initially proposed 10 lean, trained subjects would go through a period of detraining and overeating (2.5 days), which has been previously demonstrated by our
laboratory to decrease baseline insulin action (26). Following the period of de-training
and overeating subjects would complete, in random order, four experimental conditions:
high carbohydrate, galactose (an alternative moderate glycemic index carbohydrate),
low-carbohydrate, and a no-exercise control – separated by a one-week washout period.
Subjects would come into the laboratory in the early evening and complete an intense
exercise session designed to expend 30% of total daily energy expenditure (TDEE) at
65% of VO2peak. Thirty minutes following the completion of exercise subjects would
consume the post-exercise meal and blood was to be drawn for one hour to measure
glucose and insulin concentrations. Blood glucose and insulin measurements were to be
taken to quantify the glucose and insulin response to the post-exercise meal. After blood
sampling, subjects would return home, fast overnight, and report back to the lab the next
morning for a measurement of insulin action.

3.2 Actual Study Design
Experimental the hypotheses and study design were streamlined to be more cost
effective and scientifically sound. Sedentary, overweight subjects will be recruited
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instead of physically fit, lean individuals, and one of the experimental conditions
(galactose, the alternate form of moderate glycemic index carbohydrate) will be
eliminated. Thus, the experimental conditions will allow us to focus specifically on the
effect of high-carbohydrate availability vs. low-carbohydrate availability following
exercise in a relevant subject population to which we hope to apply our findings.
An addition to the proposed study design is the regulation of food intake during
the day of exercise, also making the methods stronger scientifically. In all conditions
subjects will consume the same foods prior to exercise or the standardized evening
meal. Since energy imbalance has an independent effect on insulin action, the regulation
of pre-exercise food intake is important to minimize confounding variables in this study.
The actual experimental protocol (Figure 1A) is similar to the one proposed.
Subjects will come into the lab in the early evening and expended 30% of total daily
energy expenditure at 65% of VO2peak. Fifteen minutes following the completion of
exercise, a background blood draw will be taken. Thirty minutes following the
completion of exercise, subjects will consume an isocaloric meal (either high or low in
carbohydrate) to replace expended energy and blood sampling will occur every fifteen
minutes thereafter for one hour to quantify the glucose and insulin response to the postexercise meal. After the completion of blood sampling, subjects will be instructed to
consume only water overnight and returned home. The next morning (12 hours after the
meal) subjects will return to the laboratory, fasted, for a measure of insulin action using
the continuous infusion of glucose with stable isotope tracers (CIG-SIT) method.

18

3.3 Subject Characteristics
Ten healthy, previously sedentary subjects will be recruited from the Amherst,
Massachusetts area for this study. All included subjects will be between the ages of 1845 yrs, healthy (self-report as per physician evaluation within the last year), sedentary
(<1hr per week of structured physical activity) and overweight (body fat >25%).
Individuals that have a history of cardiovascular disease, Type 2 diabetes, respiratory
disease and metabolic disorders, actively trying to lose weight, taking any supplements
or medications that would interfere with testing, trying to get pregnant, and who smoke
or use tobacco products will be excluded. Participation in this study is voluntary and
subjects will be required to sign an informed consent approved by the Institutional
Review Board for human subjects at the University of Massachusetts upon inclusion in
the study.

3.4 Pre-Treatment Testing
Before starting the experimental conditions, subjects will undergo measurements
of body composition (DXA), resting energy expenditure, and maximal aerobic capacity
(VO2peak).

3.4.1 Body Composition
Body composition will be measured by dual energy X-ray absorptiometry (DXA)
(Lunar, Madison, Wisconsin). The DXA scan will measure 1) percent body fat and 2)
lean body mass. Lean body mass will be used in the calculations of isotope infusion rate
during the measure of insulin action.
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3.4.2 Total Daily Energy Expenditure
Resting energy expenditure (REE) will be measured after an overnight fast.
Subjects will be familiarized with the equipment: nose piece, head gear, two-way
mouthpiece, and the metabolic cart. After being oriented to the equipment, subjects will
lie supine and rest quietly for 15-20 minutes. After resting, expired gases will be
collected for 20 minutes using the TrueMax2400 Metabolic Measurement System
(Paromedics, Salt Lake City, Utah). Total daily energy expenditure (TDEE) will be
calculated by multiplying REE by an appropriate activity factor for young, sedentary
individuals (46).

3.4.3. Peak Aerobic Capacity
Peak aerobic capacity (VO2peak) will be measured on the cycle ergometer.
Subjects will warm-up for five minutes at a self-selected pace with low resistance. After
warming-up subjects will cycle at a self-selected “brisk” pace. Every two minutes the
resistance will be increased by 25 watts, until the subject can no longer maintain their
selected pace and voluntarily stops the test. Respiratory gases will be collected
throughout the test and recorded using a metabolic cart, (TrueMax2400, Paromedics,
Salt Lake City, Utah). Heart rate will be monitored throughout the test, (Polar
Advantage).
The test will be considered a valid measure of VO2peak if two of the three criteria
are met; 1) respiratory-exchange ratio (RER) >1.10 2) heart rate is within 15 beats of the
predicted maximum (220-age), or 3) VO2 remains constant as the resistance is increased
by 25 watts.
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3.5 Exercise Sessions
Subjects will be instructed to not engage in strenuous physical activity three days
prior to each experimental condition. Subjects will report to the lab in the evening for a
session of intense exercise. Exercise will be performed on cycle ergometer, the same
equipment used for the test of VO2peak. The exercise session is designed to expend 30%
of estimated total daily energy intake at 65% VO2peak.
To ensure subjects are exercising at 65% VO2peak respiratory gases will be
collected during the first 15 minutes of exercise, and resistance will be adjusted until the
desired steady-state intensity is achieved. At steady-state, workload (watts), RPM and
heart rate will be recorded. Subjects will be instructed to maintain the recorded RPM
and researchers will monitor heart rate for the rest of the exercise session. Total exercise
time will be calculated based on the following equations:
1. Desired energy expenditure (EE) in the exercise bout (kcal) =
30% TDEE (kcal) - EE to steady-state (kcal)
2. EE (kcal)/ minute at steady-state = EE during 10min of steady-state/10 minutes
3. Duration of exercise bout (minutes) =
Desired EE in exercise bout (kcal) / (kcal/min at steady-state)

Half-way through the exercise session, respiratory gases will be collected to
ensure subjects are still cycling at the desired intensity. Adjustments will be made to the
workload (watts) and RPM if the subject’s VO2 has deviated from the goal of 65%
VO2peak. Finally, in the last ten minutes of exercise, subjects will perform five, forty-five
second sprints alternating with a one minute and fifteen seconds rest to deplete muscle
glycogen as much as possible.
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3.6 Pre-Exercise Meals
Before each experimental condition, subjects will be instructed not to skip a
meal in the three days prior to exercise and to consume all three macronutrients
(carbohydrate, protein, and fat) at every meal as part of their normal diet.
All food will be provided to subjects on the day of the exercise session. Subjects
will come to the laboratory in the morning (8:00am) to eat breakfast and pick-up their
meals for the day. Subjects will be provided lunch, and a high-carbohydrate snack to be
consumed 3 hours before returning to laboratory for exercise. Subjects will consume the
same meals for each experimental condition, except for the last meal of the day exercise
which will be provided following exercise and vary in carbohydrate content. For the noexercise control condition, subjects will be provided a standardized meal, equal to 30%
of their estimated total daily energy intake to be consumed at home.

3.6.1 Post-Exercise Meals
Thirty minutes following the completion of the intense exercise session, subjects
will be instructed to consume a post-exercise meal and will be given 10 minutes to
complete it. Post-exercise meals will differ in macronutrient content will be designed to
vary carbohydrate availability (high or low). The high carbohydrate meal (High-CHO)
will consist of sugary Kool-aid® (8% carbohydrate) and a lightly buttered bagel. The
low carbohydrate meal (Low-CHO) will consist of Half and Half cream, mixed with
Nesquick®, and an Atkins® bar. The caloric value of both post-exercise meals is
designed to replace exercise energy expenditure (30% TDEE) and differ in carbohydrate
content. In addition, the high carbohydrate meal will replace the carbohydrate (g)
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expended during exercise (carbohydrate balance), and the low carbohydrate meal will
not (carbohydrate deficit).

3.7 Glucose and Insulin Measurements
Fifteen minutes following the completion of exercise an indwelling superficial
catheter will be inserted into one of the subject’s forearm veins and a background blood
sample will be taken. After the background blood draw, the post-exercise meal will be
consumed and blood sampling will resume 15 minutes after the meal’s completion.
Blood samples will be collected every fifteen minutes thereafter for one hour. Once each
blood is collected it will be transferred into vacutainers containing sodium fluoride and
potassium oxalate (a glycolytic inhibitor), and EDTA (an anti-coagulant). Blood
samples will immediately be centrifuged for 10 minutes at 3000g, plasma aliquots will
be stored in 2ml cryotubes at -80°C.

3.8 Assessment of Insulin Action
Subjects will report, fasted, the next morning to the laboratory for a measure of
insulin action. Insulin action will be measured using a continuous infusion of glucose
with stable isotope tracers (CIG-SIT). Indwelling superficial venous forearm catheters
will be inserted into each arm of the subject. One catheter will be used as the site of
infusion and the other for blood collection. Baseline blood samples will be collected to
determine naturally occurring levels of isotopic enrichment prior to the infusion. A
priming bolus of 200mg [6,6-2H] glucose will be given followed by a 90 minute
infusion of 2.0% [6,6-2H] glucose and [1,1,2,3,3 – D5] glycerol isotope at a rate of
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2.5mg/min delivered by a peristaltic infusion pump (Harvard Apparatus Pump 22,
Holliston MA). Resting blood samples will be collected at 75 and 90 minutes. Breath
samples will be taken from minutes 75-85 to determine resting substrate oxidation rates
using indirect calorimetry (TrueMax2400, Paromedics, Salt Lake City, Utah). At minute
90, the infusate will be changed to 20% dextrose containing 2.0% [6,6-2H] glucose
delivered at a rate of 8.45mg/kg FFM/min for 60 minutes. Steady-state blood samples
will be collected at 50, 55 and 60 minutes. Again, breath samples will be taken from
minutes 50-60 to determine steady-state substrate oxidation rates using indirect
calorimetry.
Venous blood will be collected in heparinized syringes and immediately
transferred to vacutainers containing sodium fluoride and potassium oxalate (a
glycolytic inhibitor), and EDTA (an anti-coagulant). Blood collected in vacutainers
containing a glycolytic inhibitor will be used for the analysis of plasma glucose and
glucose isotopic enrichment. Vacutainers containing an anti-coagulant will be used for
the analysis of insulin, glycerol, triglycerides and free fatty acid (FFA) concentrations.
After collection, samples will be centrifuged for 10 minutes. Following centrifugation,
plasma aliquots will be separated and stored in 2ml cryotubes and stored at -80°C until
biochemical analysis.

3.9 Biochemical Analysis
Plasma glucose concentrations will be determined by the glucose oxidase
method with a GL5 Analox Analyzer (Analox Instruments, Lunenberg, MA). Insulin
concentrations will be determined using a radioimmunoassay kit specific for human
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insulin (Millipore Research Corp., Billerica, MA). Glycerol and triglycerides
concentrations will be determined using reagents from the serum triglyceride kit using
the enzymatic hydrolysis by lipase of triglycerides to glycerol (Sigma Aldrich, St. Louis,
MO). Free fatty acid (FFA) concentrations will be determined with an NEFA enzymatic
colorimetric assay kit (Wako Chemicals USA Inc., Richmond, VA).

3.9.1 Plasma Isotopic Enrichment
Glucose isotopic enrichment will be measured by high-performance liquid
chromatography, mass spectrometry (HPLC/MS) using a protocol adopted from (44). 1
ml of acetone (CH3COCH3) will be pipetted into a labeled microcentrifuge tube. 0.3ml
of plasma will be added to the acetone to de-proteinate the sample. Samples will then be
vortexed, incubated in the freezer at -20°C for 10 minutes. After chilling, the sample
will be centrifuged for 2 minutes at 17000g and 4°C. Following centrifugation, the
sample supernatant will be removed using a 1ml luer lock plastic syringe, and
transferred through a polyethersulfone filter (4mm, 0.45µm) into a 200µl plastic insert
and then placed into a glass HPLC vial and capped (Fisher Scientific Inc., Pittsburg,
PA).
After the completion of sample preparation, the HPLC vials will be loaded into
the autosampler compartment of the HPLC (Agilent 1100 Series; Agilent Technologies,
Santa Clara CA). The HPLC method will be controlled using the Chemstation Software
package (Agilent Technologies, Santa Clara CA) with the following conditions:
isocratic mobile phase 75:25 - acetonitrile (ACN): water (H2O), flow rate 1.0 mL/min,
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injection volume 10µL, column temperature 35°C (Shodex Asahipak NH2P-50, 4.6 x
250mm, Showa Denko America Inc., New York NY), and a 10 minute run time.
Following equilibration, the samples will be injected into the system and sample
compounds will be separated using isocratic reverse phase chromatography. After
compounds are separated in the HPLC they will be ionized by an electrospray source in
the mass spectrometer (Esquire 6000, Bruker Daltonics Inc., Billerica MA) using
Esquire Control software and the mass to charge ratio of the positively ionized sample
will be detected following conditions: capillary -5500V, endplate offset -500V,
nebulizer 30.0 psi, dry gas 10.0 L/min, and dry temperature 300ºC, over a scan range of
100 to 210 m/z.
Chromatographs will be analyzed using Bruker Data Analysis software (Bruker
Daltonics Inc., Billerica MA). The glucose peaks (elution time ~7.5 minutes) will be
isolated, then integrated and the average mass to charge ratio will be generated. Isotopic
enrichment of the dideuterated glucose (mass to charge ratio = 205) will be expressed as
a percentage of the total glucose species (mass to charge ratio = 203 + 204 + 205):
% isotopic enrichment =

205
(203 + 204 + 205)
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3.10 Calculations
The necessary variables (Ra and Rd) will be calculated by:
Glucose rate of appearance (Ra) in mg/min=

F - V[(C1 + C2) / 2][(IE2 - IE1) / (t2 - t1)]
_________________________
[(IE2 + IE1) / 2]

Glucose rate of disappearance (Rd) in mg/min =

Ra - V[(C2 - C1)/ (t2 - t1)]

F represents the isotopic infusion rate. IE1 and IE2 are the isotopic enrichments (ratio of
labeled [6,6-2H] glucose to total plasma glucose) at time-points t1 and t2 respectively. C1
and C2 are the concentrations of plasma glucose at t1 and t2, and V is the estimated
volume of distribution for glucose (180 ml/kg).

3.10.1 Whole Body Insulin Action
Whole body insulin action will be calculated by dividing the glucose rate of
disappearance by the steady-state plasma insulin concentration (Rd/SSPI). Steady-state
plasma insulin concentrations will be determined by averaging the insulin
concentrations of minutes 50, 55, and 60 of the 20% glucose + isotope infusion.

3.10.2 Hepatic Insulin Action
Hepatic insulin action is defined as the percent suppression of fasting hepatic
glucose output. % hepatic suppression:

=1

HGOclamp
HGOfasting

* 100
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HGOclamp is the average Ra at minutes 50, 55, and 60 of the glucose infusion
minus the infusion rate. HGOfasting is the Ra at minutes 75 and 90. The right side of the
equation represents the amount of endogenous glucose coming from the liver during the
steady-state glucose infusion. When subtracted from 1 and multiplied by 100, the result
is percent hepatic suppression. Percent hepatic suppression is a measure of how
effectively endogenous glucose production is lowered by increased insulin
concentrations during the glucose infusion.

3.10.3 Substrate Partitioning during the Measure of Insulin Action

3.10.3.1 Non-oxidative Glucose Disposal and Carbohydrate Oxidation
Non oxidative glucose disposal (Rdnox) is calculated by subtracting the rate of
carbohydrate oxidation from the glucose rate of disappearance (Rd).
The rate of carbohydrate oxidation (Rdox) will be calculated using: 4.585 VCO2 (L/min)
– 3.226 VO2 (L/min) (47).

3.10.3.2 Fat Oxidation
Rates of fat oxidation will be calculated using: 1.695 VO2 (L/min) – 1.701
VCO2 (L/min) (47).

3.11 Statistics
A commercially available software package, (SAS, Version 8, SAS Institute,
Cary, NC) will be used to perform statistical analysis of the data. A paired t-test will be
used to compare the two exercise sessions and the glucose and insulin responses to the
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two post-exercise meals. The caloric value and composition of the post-exercise and
standardized meals will be evaluated a one-way repeated measures ANOVA. The effect
of carbohydrate availability following exercise on insulin action, hepatic insulin action,
and whole body lipolysis will also be evaluated using one-way repeated measures
ANOVA. A two-way (time x experimental condition) repeated measured ANOVA will
be used to evaluate if there is a significant effect of time (rest to steady-state) and
experimental condition on: plasma glucose, insulin, non-oxidative glucose disposal,
carbohydrate oxidation, fat oxidation, free fatty acids, triacylglycerol and glycerol. For
all statistical tests, significance will be set a p<0.05. If there is a significant effect of
time or experimental condition with the ANOVA, Tukeys post-hoc analysis will be
performed to make pair wise comparisons between group means.
A linear regression analysis (p<0.05) will be performed to evaluate a potential
relationship between carbohydrate availability in the post-exercise meal and changes in
insulin action (compared to baseline) the following morning.
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CHAPTER 4
CONDENSED MANUSCRIPT

4.1 Introduction
Insulin stimulated glucose uptake (insulin action) is increased following an acute
bout of exercise (1, 3, 9, 29, 40). The insulin-sensitizing effect of exercise (7), among its
many benefits, has led it to be characterized as a “drug” to improve metabolic health
because it reduces the risk of type 2 diabetes with repeated application (20, 36).
Metabolic health outcomes, like insulin action, are affected by the nutritional
environment following exercise. Fasting following exercise significantly increases
insulin action (2, 3); however, when expended energy is refed as dietary carbohydrate,
insulin action does not increase from baseline values (2, 3, 34).
Following exercise, it is unknown whether the reversal of enhanced insulin
action is mediated by refeeding expended energy or by refeeding expended energy as
carbohydrate. In rodents, refeeding expended energy without carbohydrate (carbohydrate
restriction) prolongs increased insulin action until carbohydrate is refed (5, 12, 41);
supporting that the carbohydrate may be responsible for blunting the effect of exercise.
Carbohydrate restriction (following exercise) may be a sensible strategy to enhance
insulin action in humans, but its effect has not been systematically evaluated. Therefore,
the purpose of this study was to evaluate the effect of carbohydrate availability
following exercise on insulin action in sedentary, overweight adults. It was hypothesized
that, relative to baseline (BASE), carbohydrate restriction following an exercise bout
(Low-CHO) would increase whole-body insulin action but that replacing the expended
energy as carbohydrate (High-CHO) would not.
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4.2 Methods

4.2.1 Subjects
Subject characteristics are shown in Table 1. Ten volunteers - five men and five
women – participated in the study. Subjects were young (age=22.2±1.0 years),
overweight (BMI=26.1±3.7 kg × m-2) and had a low level of cardiorespiratory fitness,
(VO2peak=34.6±3.8 mL × kg-1 × min-1).
For inclusion, subjects completed a health and fitness questionnaire and had
preliminary measurements taken. Subjects were sedentary (<1 hr leisure time physical
activity per week for 3 months), weight stable for the past 6 months, and had a body fat
% > 25. None of the subjects had type 2 diabetes, cardiovascular disease, respiratory
disease, metabolic disorders or used tobacco products, nor were they taking any drugs or
supplements that would interfere with the measure of insulin action (e.g. anti-diabetic
drugs, blood pressure medication, statins, insulin, inhaled steroids, chromium, and
ephedra). The experimental protocol was approved by the Institutional Review Board
for human subjects at the University of Massachusetts and prior to participation, written
consent from subjects was obtained. If subjects were non-compliant with study protocol
(1 subject) or unable to successfully perform preliminary measurements (1 subjects),
they were excluded from the study and their data were not analyzed.

4.2.2 Preliminary Measurements
Resting Energy Expenditure: Subjects reported to the laboratory the morning
following an overnight fast. After familiarization with the laboratory and its equipment,
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subjects rested quietly for 25 minutes, lying supine. After resting, respiratory gases were
collected for a minimum of 20 minutes using the TrueMax2400 Metabolic
Measurement System (Parvomedics, Salt Lake City, Utah) and indirect calorimetry
determined resting energy expenditure. An estimate of total daily energy expenditure
(TDEE) was calculated by multiplying measured resting energy expenditure by an
activity factor representative of sedentary physical activity patterns (25). Body
Composition: Fat mass, fat-free mass, and % body fat was assessed by dual-energy Xray absorptiometry (DXA) (Lunar, Madison, Wisconsin). Peak Oxygen Consumption:
All subjects performed a progressive, incremental cycling test to exhaustion to measure
peak oxygen consumption (VO2peak mL× kg-1×min-1) on an electronically braked cycle
ergometer, (SensorMedics 800, Yorba Linda, CA). The test was considered valid if: 1)
respiratory-exchange ratio (RER) >1.10, 2) heart rate was within 15 beats of the
predicted maximum (220-age), or 3) if VO2 did not continue to increase with an
increased resistance of 25 watts.

4.2.3 Experimental Protocol
Subjects completed three experimental conditions (each lasting two days) in
random order: 1) a baseline measure of insulin action (BASE), 2) exercise followed by a
high carbohydrate meal (High-CHO) and 3) exercise followed by a Low-CHO meal
(Low-CHO). A minimum of one-week separated each experimental condition.
Figure 1 illustrates the two-day testing protocol timeline. On Day 1 of the
exercise conditions, subjects reported to the laboratory in the early evening (1700h) and
expended 30% of their TDEE, at 65% of VO2peak on a cycle ergometer. Fifteen minutes

37

following the completion of exercise, a background blood draw was taken. Thirty
minutes following the completion of exercise, subjects consumed a meal (either high or
low in carbohydrate) that replaced all of the expended energy and blood sampling
occurred every fifteen minutes thereafter for one hour (to quantify the glucose and
insulin response to the post-exercise meal). After the completion of blood sampling,
subjects were instructed to consume only water overnight and were sent home. The next
morning (Day 2), approximately 12 hours after the post-exercise meal, subjects returned
to the laboratory for a measure of insulin action using a continuous infusion of glucose
with stable isotope tracers (2).

4.2.4 Pre-Exercise Meals
On Day 1 in all conditions, subjects consumed similar meals prior to exercise or
the standardized evening meal, in the BASE condition. Subjects came to the laboratory
in the morning (8:00am) to eat breakfast and receive pick-up the other meals for the day.
Subjects were given lunch and an afternoon snack to eat on their own at given times
(1200h and 3hr before exercise, respectively). As a measure of compliance, subjects
were instructed to bring all empty food containers back to the laboratory. In the BASE
condition, subjects were also given a standardized evening meal (724.3 ± 35.2kcal; 54.1
± 1.6 % carbohydrate, 32.7 ± 0.7 % fat and 9.2 ± 1.1 % protein) to be eaten at home 12
hours prior to measurement of insulin action.
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4.2.5 Exercise Sessions
Subjects were instructed, and agreed, not to engage in moderate physical activity
at least three days prior to each experimental condition. On Day 1 of the Low-CHO and
High-CHO experimental conditions, subjects reported to the laboratory at ~ 1700h for
exercise on a cycle ergometer (Lifefitness, Champaign, IL) at 65% of VO2peak.
Respiratory gases were collected during the first 15 minutes of exercise bout,
until desired steady-state VO2 (mL× kg-1×min-1) was achieved. At steady-state, the
workload (watts), RPM and heart rate were recorded. Energy expenditure per minute at
steady-state (kcal/min) was recorded and subjects cycled for the time necessary to
expend 30% TDEE.
Half-way through the exercise session, respiratory gases were collected to verify
subjects were cycling at the desired intensity. Adjustments were made to the workload
and RPM if the subject’s VO2 (mL× kg-1×min-1) had deviated from the goal of 65% of
VO2peak. Exercise time was also re-calculated if necessary. In the last ten minutes of
exercise, subjects performed five 45 second sprints alternating with 75 seconds rest to
deplete muscle glycogen as much as possible.

4.2.6 Post-Exercise Meals and Blood Sampling
Fifteen minutes following exercise completion an indwelling catheter was
inserted into a superficial forearm vein and a background blood sample was taken.
Thirty minutes following exercise completion subjects were given a meal either high
(76.6±2.5%) or low (17.8±0.1%) in carbohydrate that replaced the energy expenditure
of exercise (~700kcal). In addition, the High-CHO meal replaced all carbohydrate
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expenditure (grams) during exercise. Blood samples were collected every fifteen
minutes after the meal’s completion for one hour to verify the post-exercise meals
resulted in different glucose and insulin responses.

4.2.7 Assessment of Insulin Action: Glucose Infusion with Stable Isotopes
Insulin action was assessed 12 hours following the post-exercise meal on the
morning of Day 2 using a continuous infusion of 20% glucose containing 2% stable
[6,6-2H] isotope (Cambridge Laboratories, Andover MA). Subjects rested quietly in a
reclining chair and an indwelling superficial venous forearm catheter was inserted into
each arm. One catheter was used for infusion of stable isotopes and the other was used
for blood collection. Baseline blood samples were collected to determine naturally
occurring isotopic enrichment prior to the infusion. A priming bolus of 200mg [6,6-2H]
glucose was given followed by a 90 minute infusion of 2% [6,6-2H] glucose at a rate of
2.5mg/min delivered by a peristaltic infusion pump (Harvard Apparatus Pump 22,
Holliston MA). Resting blood samples and respiratory gases were collected at 75 and 90
minutes. At minute 90, the infusate was changed to 20% glucose containing 2% [6,62

H] glucose, delivered at a rate of 8.45mg/kg FFM/min for 60 minutes. Steady-state

blood samples and respiratory gases were collected at 50, 55 and 60 minutes.
Resting and steady-state blood samples were collected to determine the glucose
rate of appearance (Ra) and disappearance (Rd) during the glucose infusion. Glucose and
insulin concentrations from minutes 50, 55 and 60 were averaged to determine steadystate plasma glucose (SSPG) and insulin (SSPI) concentrations. Respiratory gases were
collected and used in calculations of substrate utilization or storage.
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4.2.8 Blood Collection and Analytical Procedures
Venous blood was collected in heparinized syringes and immediately transferred
to vacutainers (kept on ice) which contained either a glycolytic inhibitor (sodium
fluoride and potassium oxalate) for later measurement of plasma glucose concentrations
and glucose isotopic enrichment, or an anti-cogulant (K3-EDTA) for insulin and free
fatty acid concentrations. After collection, samples were centrifuged for 10 minutes at 3
000g, then plasma aliquots were separated and stored in 2ml cryotubes at -80°C until
biochemical analysis.
Plasma glucose concentrations were determined by the glucose oxidase method
using a GL5 Analox Analyzer (Analox Instruments, Lunenberg, MA). Insulin
concentrations were determined using a radioimmunoassay kit specific for human
insulin (Millipore Research Corp., Billerica, MA). Free fatty acid (FFA) concentrations
were determined with an NEFA enzymatic colorimetric assay kit (Wako Chemicals
USA Inc., Richmond, VA).
Glucose isotopic enrichment was determined by high-performance liquid
chromatography mass spectrometry (LCMS) (24). Liquid chromatography was
performed with an Agilent 1100 Series, (Agilent Technologies, Santa Clara, CA)
running Chemstation 1100 software. A Shodex Asahipak NH2P-50, 4.6 x 250mm
column (Showa Denko America Inc., New York NY) was used. Mass spectrometry was
performed using an Esquire 6000, and chromatographs were analyzed with Bruker Data
Analysis software (Bruker Daltonics Inc., Billerica MA).
To de-proteinate the sample, 0.3mL of plasma was added to 1 mL of ice-cold
acetone (CH3COCH3). Samples were vortexed and incubated at -20°C for 10 minutes;
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after chilling, samples were centrifuged for 2 minutes at 17000g and 4°C. Following
centrifugation, the sample supernatant was transferred through a polyethersulfone filter
(4mm, 0.45µm) into a glass HPLC vial and capped (Fisher Scientific Inc., Pittsburg,
PA). Vials were loaded into the autosampler compartment of the LCMS and set to an
injection volume of 10µL. The liquid chromatography conditions were: isocratic mobile
phase 75:25 - acetonitrile (ACN): water (H2O); flow rate 1.0 mL/min; injection volume
10µL; a column temperature 35°C; 10 minute run time.
After being separated in the HPLC samples were ionized by an electrospray
source in the mass spectrometer and detected with the following conditions: capillary 5500V; endplate offset -500V; nebulizer 30.0 psi; dry gas 10.0 L/min; dry temperature
300ºC; scan range of 100 to 210 m/z.
In chromatogram analysis, the glucose peaks were isolated, integrated and the
average mass to charge ratio was generated. Isotopic enrichment of the dideuterated
glucose (mass to charge ratio = 205) was expressed as a percentage of the total glucose
species (mass to charge ratio = 203 + 204 + 205):
% isotopic enrichment =

205
(203 + 204 + 205)

4.2.9 Calculations
Fasting insulin action (HOMA-IR) was calculated by: (fasting plasma glucose ×
fasting plasma insulin) ÷ 22.5 (23). Insulin action during the glucose infusion (C-ISI)
was calculated by: 10,000 ÷ √((fasting plasma glucose × fasting plasma insulin) ×
(SSPG × SSPI)) (22).
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Resting and steady-state insulin stimulated glucose turnover was calculated by:
Glucose rate of appearance (Ra) in =

F -_______________________________
V[(C1 + C2) / 2][(IE2 - IE1) / (t2 - t1)]
[(IE2 + IE1) / 2]

Glucose rate of disappearance (Rd) =

Ra - V[(C2 - C1) / (t2 - t1)]

F represents the isotopic infusion rate. IE1 and IE2 are the isotopic enrichments (ratio of
labeled [6,6-2H] glucose to total plasma glucose) at time-points t1 and t2 respectively. C1
and C2 are the concentrations of plasma glucose at t1 and t2, and V is the estimated
volume of distribution for glucose of 180 mL/kg.
Whole body insulin action was determined by Rd/SSPI (2, 4, 34).
Nonoxidative glucose disposal, usually attributed to glucose storage, was calculated as
(Rdnox): Glucose Rd – total carbohydrate oxidation rate (Rdox).
Carbohydrate and fat oxidation rates were calculated from the VO2 and VCO2
(L/min) using the formulas of Péronnet and Massicotte (26):
Fat oxidation rate = 1.6946 VO2 – 1.7012 VCO2
Carbohydrate oxidation rate = 4.5850 VCO2 – 3.2255 VO2
Hepatic glucose production (HGP) was calculated as the difference between Ra and
the total glucose infusion rate. Hepatic insulin action was defined as the % suppression
of resting hepatic glucose production by the glucose infusion during steady-state. %
suppression was calculated by: 1 – (HGPinfusion÷ HGPrest) × 100.
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4.2.10 Statistics
Data was analyzed using SAS Version 9.1 (SAS Institute, Cary, NC). A paired ttest was used to compare exercise sessions, as well as, the glucose and insulin responses
to the post-exercise meals. The caloric value and composition of the meals was
evaluated using one-way repeated measures ANOVA, which was also used to evaluate
the effect of carbohydrate availability following exercise on: insulin action, Rd, Rdox,
Rdnox, and % hepatic suppression. A two-way (time × experimental condition) repeated
measures ANOVA was used to evaluate whether a significant effect of time (rest to
steady-state) and experimental condition existed in: plasma glucose, insulin, FFA
concentrations, hepatic glucose production, and rates of fat oxidation. If significance
was observed, Tukeys post-hoc analysis was performed.
Regression analysis was used to further evaluate outcome variables. The strength
of linear relationships is presented as the Pearson’s product moment correlation
coefficient (R). For all statistical tests, a p value less than 0.05 was considered
significant.

4.3 Results

4.3.1 Exercise Sessions
By design, the two intense exercise sessions (High-CHO and Low-CHO) were
similar in exercise intensity (% VO2peak), caloric expenditure (kcal), carbohydrate
expenditure (total grams carbohydrate), and duration (minutes), (p>0.05, for each).
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Respiratory exchange ratios (RER), measured during steady-state exercise were also
similar in both exercise sessions (p=0.78), (Table 2).

4.3.2 Post-Exercise Meals
The caloric content of the post-exercise meals was not significantly different
between conditions, nor different from BASE, (p=0.52), as shown in Table 3. Meals
were significantly different in the amount of carbohydrate (g), % carbohydrate, amount
of fat (g), and % fat (p<0.001 for each, respectively). The High-CHO and BASE meals
were similar in protein content (p=0.10) and % protein (p=0.14), but both meals were
significantly lower in protein content (~ 15g) and % protein (~10%) compared to the
Low-CHO meal (p<0.001). By design, the High-CHO condition was in carbohydrate
balance; 139.6 ± 9.8g of carbohydrate were expended during exercise and the postexercise meal contained 138.9 ± 8.4g of carbohydrate. The Low-CHO condition was in
carbohydrate deficit; the difference between the carbohydrate consumed (30.8 ± 1.3g)
and expended (139.7 ± 9.8g) was approximately 100 grams.
Glucose and insulin concentrations vs. time are shown in Figure 2. Areas under
the curve (AUC) for the glucose and insulin responses to the post-exercise meals were
calculated using trapezoidal integration. By design, the glucose AUC following the
High-CHO meal was significantly greater than the glucose AUC following the LowCHO meal (p<0.001). As expected, the insulin AUC following the High-CHO meal was
also significantly greater than the Low-CHO meal (p<0.001).
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4.3.3 Fasting Plasma Glucose and Insulin Concentrations
In response to carbohydrate restriction following exercise (Low-CHO), fasting
plasma glucose concentrations the next morning were significantly lower (p<0.05)
compared to BASE and High-CHO conditions, (Table 3). Fasting insulin concentrations
were similar between groups (p=0.64). The HOMA – IR was not also not different
between conditions (p=0.38).

4.3.4 Glucose Metabolism
The insulin stimulated rate of glucose disappearance (Rd) was similar between
conditions (p=0.39), (Table 4). When the Rd was separated into its non-oxidative
(Rdnox) and oxidative (Rdox) components (Figure 3), Rdnox was higher compared to
BASE following the Low-CHO condition (p<0.05), but not the High-CHO condition
(p=0.06), (Table 4). Rdox decreased following both exercise conditions compared to
BASE (p<0.05). When the exercise conditions were compared, the Low-CHO treatment
reduced Rdox 20% more than the High-CHO treatment did (p<0.05).
There was no effect of post-exercise carbohydrate availability on insulin action,
as defined by glucose uptake (Rd) per steady-state plasma insulin (SSPI), (p=0.30). The
C-ISI score was also not different between experimental conditions (p=0.55). Lastly,
hepatic glucose production at rest (HGPrest) and % hepatic suppression during the
glucose infusion was not affected by experimental treatment; there was no difference
between conditions (p=0.98 and p=0.54, respectively), (Table 4).
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4.3.5 Lipid Metabolism and Fat Oxidation
Resting FFA were elevated following the Low-CHO condition (p<0.05) but not
the High-CHO condition (p=0.28) compared to BASE (Table 5), and were not different
between Low-CHO and High-CHO conditions (p=0.45). The glucose infusion
significantly reduced FFA concentrations (p<0.01) by similar magnitudes in all
conditions (p=0.49). As in the fasted state, FFA concentrations were elevated during the
infusion in the Low-CHO condition compared to BASE (p<0.05) and were not different
between Low-CHO and High-CHO conditions (p=0.13).
Resting fat oxidation rates were higher following in Low-CHO compared to
BASE but not High-CHO, (Low-CHO condition p=0.04, High-CHO condition p=0.23),
(Figure 4). Fat oxidation was lower during the glucose infusion compared to rest in the
BASE condition (∆-45.6±9.5 mg×min-1, p<0.01), (Table 5). In contrast, the glucose
infusion did not affect fat oxidation rates in the Low-CHO and the High-CHO
conditions: they remained elevated (during the infusion) compared to rest (∆-19.4 ± 7.2
mg×min-1, P=0.72 and ∆-34.0 ± 8.7 mg×min-1, p=0.32) and to BASE (p<0.05 for both
conditions, respectively). Fat oxidation remained elevated to a greater degree in the
Low-CHO condition compared to the High-CHO condition (93.4 ± 10.6 and 72.0 ± 7.4
mg × min-1, respectively, p=0.05).

4.3.6 Correlations
Changes in insulin action relative to BASE (∆ Rd/SSPI) after the exercise/meal
treatments were inversely related to insulin AUC following the post-exercise meals (r
=−0.45, p=0.06), and resting FFA concentrations the next morning (r =−0.49, p=0.03).
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To further explain the differences in ∆ Rd/SSPI observed in each condition, the ∆
Rd/SSPI data was separated by Low-CHO and High-CHO condition and analyzed using
linear regressions.
∆ Rd/SSPI of the High-CHO condition was inversely correlated to insulin AUC
following the High-CHO post-exercise meal (r =−0.79, p=0.01) and resting FFA
concentrations (r = − 0.78, p=0.007). ∆ Rd/SSPI of the Low-CHO condition was also
inversely correlated with insulin AUC and FFA (r =− 0.39, r =−0.55, respectively);
however, both associations were weaker and neither was significant (p=0.30, p=0.09).
Interestingly, ∆ Rd/SSPI in the Low-CHO condition was strongly correlated with the
magnitude of carbohydrate deficit achieved with the post-exercise meal (r = 0.82,
p=0.003), as shown in Figure 5. ∆ Rd/SSPI was directly correlated with
cardiorespiratory fitness (VO2peak) in the High-CHO condition (r = 0.68, p=0.030) but
not in the Low-CHO condition (r=0.03, p >0.05), (Figure 6). Lastly the rate of fat
oxidation during the glucose infusion was directly correlated with insulin action (r =
0.56, p=0.01).

4.4 Discussion
The purpose of this study was to evaluate the effect of post-exercise
carbohydrate availability on insulin action in sedentary, overweight adults. It was
hypothesized that, relative to baseline, insulin action would be improved when exercise
was followed by carbohydrate restriction (Low-CHO) but not when expended
carbohydrate was refed (High-CHO). Contrary to our hypothesis, insulin action defined
by glucose uptake per unit steady-state insulin was not affected by experimental
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condition. However, the Low-CHO condition altered glucose and lipid metabolism at
rest and in response to a glucose infusion compared to BASE and the High-CHO
condition.
In the Low-CHO condition resting fat oxidation was increased and glucose
concentrations were decreased compared to BASE. During the glucose infusion, nonoxidative glucose disposal (Rdnox) was increased and glucose oxidation (Rdox) reduced.
Lastly, the magnitude of carbohydrate deficit, i.e. the difference between carbohydrate
expenditure and intake following exercise, was positively associated with changes in
insulin action relative to baseline the next morning. Our results suggest that inducing a
large carbohydrate deficit after exercise by refeeding energy (mainly as fat with
relatively little carbohydrate) enhances the effects of exercise on glucose and lipid
metabolism and may be a useful strategy following exercise to counter impaired insulin
action in sedentary, overweight adults.

4.4.1 Glucose Storage and Oxidation
The storage and oxidation of glucose cleared from the blood during the glucose
infusion was affected by carbohydrate availability following exercise. Consistent with
the results of other studies (3, 9), we found an acute bout of exercise increased Rdnox
(generally assumed to represent glucose storage), and decreased the rate of Rdox during
the glucose infusion. Lean, insulin-sensitive individuals have elevated Rdnox and lower
Rdox during a glucose infusion compared to their overweight, insulin resistant
counterparts (9, 18). In obese individuals, exercise shifts glucose metabolism toward,
but not completely to, the profile typically observed in lean individuals (9). We
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observed this pattern, i.e. a shift in glucose disposal toward greater storage and away
from oxidation following the Low-CHO condition but not the High-CHO condition.
Similarly, Bogardus et al. reported increased Rdnox and decreased Rdox after a bout of
glycogen-depleting exercise when subjects fasted after exercise but not when they
consumed 100grams of carbohydrate (3). Our results extend the findings of Bogardus et
al. by supporting that the effect of prior exercise to bias glucose disposal toward greater
storage is attributable to limited carbohydrate intake rather than energy intake; following
exercise in both the High-CHO and Low-CHO conditions, all expended energy was
refed.

4.4.2 Insulin Action
Insulin action was not improved after exercise in the High-CHO condition,
consistent with prior results from our laboratory (2) and studies done in rodents (5, 12,
41). We hypothesized that carbohydrate restriction (Low-CHO) after exercise would
promote greater increases in insulin action than the High-CHO condition but,
surprisingly, we observed that, insulin action was not affected by carbohydrate
availability. The mean change from baseline was approximately +15% in either
condition which was not statistically significant. A 15% increase in insulin action,
measured 12-14 hours after a single bout of exercise is consistent with what others have
shown (1, 3) but smaller than reported increases following exercise of higher intensity
(40). Our data are very similar to a those documented in a study by Ben-Ezra et al., who
also carefully matched energy intake with exercise energy expenditure following
exercise; they observed a 15% increase in insulin action the next morning (1).
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In the Low-CHO condition there was a strong positive relationship between
∆Rd/SSPI and carbohydrate deficit – implying that the greater the carbohydrate deficit
following exercise, the bigger the enhancement of insulin action relative to baseline. A
similar relationship was not observed in the High-CHO condition because subjects were
kept in carbohydrate balance (by design) and carbohydrate expenditure matched intake;
therefore, there was no carbohydrate deficit in the High-CHO condition to use as a
predictor of insulin action. However, in the High-CHO condition we observed a direct
relationship between the ∆Rd/SSPI and cardiorespiratory fitness (VO2peak).
A well-known relationship exists between insulin action and cardiorespiratory
fitness: individuals with high cardiorespiratory fitness have higher insulin action than
individuals with low cardiorespirtatory fitness (13, 19). Our results suggest that insulin
action in sedentary, overweight adults with a higher cardiorespiratory fitness
(presumably due to genetic factors since they are sedentary) may respond more robustly
to exercise than those with low cardiorespiratory fitness. Indeed, the two subjects with
the lowest VO2peak had decreased insulin action following exercise compared to
baseline.
The strong positive relationship observed between carbohydrate deficit and
∆Rd/SSPI in the Low-CHO condition may be related to the incomplete replenishment of
muscle glycogen that results from restricting carbohydrate intake after exercise (6). Low
muscle glycogen concentrations are associated with increased insulin action and
glycogen promoting enzymes (8, 12, 16, 17). Since we did not measure glycogen
concentrations or enzymatic activity, we have a limited ability to draw conclusions
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about how glycogen concentration impacted insulin action but it is plausible that muscle
glycogen concentrations were lower the Low-CHO condition compared to High-CHO.
There is evidence that insulin action following exercise may be regulated by
mechanisms other than a relationship with low muscle glycogen concentrations.
Bogardus et al. demonstrated muscle glycogen concentrations were similar regardless of
whether individuals fasted or consumed 100grams of carbohydrate following exercise
(3). Despite similar muscle glycogen concentrations, insulin action was different and
enhanced only in the fasted condition. An alternate mechanism to glycogen
concentrations mediating insulin action is that elevated insulin levels following
carbohydrate intake have an effect on metabolic gene expression (27) and on the activity
of glycogen promoting enzymes like glycogen-synthase kinase-3 (GSK-3) and protein
kinase B (PKB or Akt) (38, 39). Pilegaard et al. (27) recently found, exercise followed
by high carbohydrate meals, reversed the elevated expression of genes encoding
oxidative transport proteins at the mitochondria; when exercise was followed by low
carbohydrate meals, the expression of oxidative genes remained elevated.
At the whole body level, our data support that insulin action is being partially
mediated by the insulin response to a post-exercise meal. We measured the glucose and
insulin response to the post-exercise meals and, as expected, the insulin response to the
High-CHO meal was considerably higher than the response to the Low-CHO meal. The
insulin area under the curve (AUC) in response to the High-CHO post-exercise meal
had a strong negative relationship to ∆Rd/SSPI in the High-CHO condition; the greatest
enhancement in insulin action was following a smallest insulin response to the HighCHO meal. A relationship between insulin AUC and ∆Rd/SSPI the Low-CHO condition
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was not observed; plasma insulin concentrations were elevated significantly less by the
Low-CHO meal than the High-CHO meal and carbohydrate deficit was the best
predictor of ∆Rd/SSPI in the Low-CHO condition. Whether the insulin response to the
High-CHO meal is causally related to ∆Rd/SSPI cannot be determined by our study and
more research is required to address this mechanistic question.

4.4.3 Lipid Metabolism
In order to reduce carbohydrate intake but still reefed all of the expended energy
back following exercise, subjects consumed more fat (+30g) in the Low-CHO condition
compared to the High-CHO condition. In agreement with a series of studies from the
Horowitz Laboratory, we found that insulin action was not impaired by increased fat
availability following exercise. It has been hypothesized that exercise may be protective
against fatty acid induced insulin resistance (30) because it increases lipid oxidation (15,
32, 33, 37) as well as increases the synthesis of intramyocellular lipids (IMCL) (31).
This theory rests on the idea that by directing muscle fatty acids to oxidation or
triacylglycerol synthesis, there is less accumulation of fatty acid moieties (diacylglycerol
and ceramide) that may interfere with insulin signaling. We did not measure IMCL
synthesis or diacylglceryol and ceramide concentrations, although we did measure
whole-body fat oxidation and observed it was elevated in the Low-CHO condition
compared to BASE. As Randle et al. (28) first demonstrated, increased fat availability
usually impairs insulin action (14, 21) but this effect is not observed when high fat
intake (or a lipid infusion) occurs against a background of glycogen-depleting exercise
(11, 30, 31, 35). Similarly, we found insulin action following exercise was similar
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between the Low-CHO and High-CHO conditions despite the consumption of more
dietary fat in the Low-CHO condition.

4.4.4 Future Directions
Maximizing the effectiveness of each exercise bout to improve metabolic health
is important to sedentary, overweight individuals beginning an exercise program. In
addition, the nutritional environment after exercise likely plays a large role in the
accrual of exercise benefits on metabolic health. Recently, our laboratory found six-days
of endurance exercise followed by high carbohydrate availability blunted the effect of
exercise to increase insulin action in sedentary, overweight individuals (2). At the
cellular level, expression of genes related to energy metabolism is sensitive to
carbohydrate availability (27). We demonstrated, at the whole body level, that measures
of glucose and lipid metabolism were also sensitive to carbohydrate availability when
energy expenditure was matched with energy intake following exercise. We propose
limiting carbohydrate intake after exercise in sedentary, overweight individuals. This
strategy may promote greater gains in metabolic health over time compared with
unregulated carbohydrate intake; high carbohydrate availability mutes the effects of
exercise on metabolic health, but low carbohydrate availability does not.

4.4.5 Limitations
By design, we did not include an experimental condition that fasted (energy
deficit) following exercise. The objective of the study was to evaluate the impact of
varying carbohydrate availability without the confounding effects of energy imbalance
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thus we refed all of the expended energy back following exercise. A logical future
would be to add an energy deficit condition to the existing study design to determine
how restricting all expended energy compares with restricting only carbohydrate energy.
Then it may be determined which strategy may be the best one to maximize the
effectiveness of exercise on insulin action; an important question that remains
unanswered.
Also, we did not keep protein intake constant in the three experimental
conditions. Matching protein intake in all conditions would have been optimal to
minimize any impact of differences in protein content on the results. However, adding
protein to carbohydrate exaggerates the insulin response by the pancreas (10) which
could have compromised our goal of assessing how the insulin response to low or highcarbohydrate availability following exercise is related to the magnitude of change in
insulin action.

4.4.6 Summary
It was demonstrated that whole body glucose and lipid metabolism in sedentary,
overweight individuals is shifted toward the metabolic profile of a lean individual (e.g.
greater glucose storage and higher fat oxidation) by carbohydrate restriction following
exercise. Interestingly, this shift was accomplished independently of an energy deficit
and did not require total restriction of daily carbohydrate intake. The Institute of
Medicine 2005 Dietary Guidelines for Americans suggests adults consume between 4565% of total daily caloric intake as dietary carbohydrate. In the Low-CHO condition,
total daily carbohydrate intake was 48.2 ± 1.3% of the total daily energy intake.
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Further research is necessary to determine the compound effect of carbohydrate
restriction on metabolic health outcomes like insulin action. Before recommending that
sedentary, overweight individuals choose low-carbohydrate foods when they eat a postexercise meal, it must also be determined how this strategy may affect future exercise
performance or other factors that predict metabolic health, besides insulin action.
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Table 1. Subject Characteristics

Age (yrs)
Height (m)
Weight (kg)
BMI (kg/m2)
Body Fat %
FFM (kg)
RMR (kcal/day)
TDEE (kcal)
VO2peak (L/min)
VO2Peak
(mL/kg/min)

Mean ± SD
22.2 ± 1.0
1.71 ± 0.71
76.2 ± 13.0
26.1 ± 3.7
33.5 ± 7.9
47.6 ± 11.0
1730 ± 268
2420 ± 376
2.63 ± 0.15
34.6 ± 3.8

All values are expressed as means ± standard deviation (SD). N=10; n=5, men and n=5,
women.
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Table 2. Exercise Characteristics

VO2 (mL/kg/min)
% VO2peak
Energy Expenditure (kcal)
RER
Carbohydrate Expenditure (g)
Exercise Duration (min)

LOW-CHO

HIGH-CHO

P value

23.89 ± 0.86
69.03 ± 1.32
725 ± 35
0.94 ± 0.012
139.5 ± 11.0
83.5 ± 3.5

23.83 ± 0.81
69.25 ± 1.86
726 ± 35
0.94 ± 0.016
139.7 ± 9.8
83.5 ± 3.0

0.84
0.78
0.34
0.78
0.41
0.57

All values are expressed as means ± SEM. p >0.05 denotes non-significance. VO2,
oxygen consumption; RER, respiratory exchange ratio.
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Table 3. Day 1 Food Records

CONTROL

LOW-CHO

HIGH-CHO

P value

Daily Energy Intake (kcal)

2457.5 ± 105.0

2442.6 ± 96.2

2452.9 ± 107.0

0.950

PM Meal (kcal)
Meal Carbohydrate (g)
Meal Fat (g)
Meal Protein (g)
% Carbohydrate
% Fat
% Protein

724.3 ± 35.2
96.5 ± 2.9
27.7 ± 1.1
16.8 ± 1.5
54.1 ± 1.6
32.7 ± 0.7
9.2 ± 1.1

689.8 ± 29.5
30.8 ± 1.3ab
43.8 ± 2.ab
32.5 ± 1.7ab
17.8 ± 0.1
56.9 ± 0.4
18.7 ± 0.3

724.2 ± 35.5
138.9 ± 8.4a
12.6 ± 1.6a
13.5 ± 1.3
76.6 ± 2.5
15.8 ± 2.4
7.3 ± 0.7

0.520
0.001
0.001
0.001

Values are means ± SEM. a Significantly different from Control, (p<0.05).
b
Significantly different from High-CHO, (p<0.05).
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Table 4. Plasma Metabolites

CONTROL

LOW-CHO

HIGH-CHO

P value

GlucoseRest (mM)

5.2 ± 0.2

4.8 ± 0.3ab

5.1 ± 0.3

0.001

GlucoseInfusion (mM)

9.3 ± 0.5*

9.1 ± 0.5*

9.3 ± 0.7*

0.197

InsulinRest (ρM)

74.4 ± 9.6

66.6 ± 9.0

67.6 ± 8.1

0.644

266.2 ± 34.1*

253.9 ± 43.1*

268.4 ± 33.4*

0.888

2.9 ± 0.4
4.1 ± 0.6

2.4 ± 0.4
4.9 ± 0.9

2.6 ± 0.4
4.4 ± 0.8

0.377
0.546

InsulinInfusion (ρM)
HOMA-IR
C-ISI

Values are means ± SEM. *Significantly different from Rest (p<0.01). a Significantly
different from Control, (p<0.05). b Significantly different from High-CHO, (p<0.05). Rest,
CIG-SIT time points 75, 90 minutes averaged; Infusion, CIG-SIT time points 50, 55, 60
averaged.
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Table 5. Glucose Metabolism
CONTROL

LOW-CHO

HIGH-CHO

P value

Glucose Rdtot (µM/kg/min) Rest

10.2 ± 0.7

10.2 ± 0.9

11.0 ± 1.2

0.980

Glucose Rdtot (µM/kg/min) Infusion

33.2 ± 2.7*

35.7 ± 3.6*

37.1 ± 3.5*

0.389

Rdox (µM/kg/min) Infusion

17.1 ± 2.2

8.6 ± 1.3ab

12.2 ± 1.2

0.005

Rdnox (µM/kg/min) Infusion

16.9 ± 3.5

27.2 ± 3.2a

24.9 ± 3.7

0.042

Insulin Action (µg/kg/min/pM)

26.4 ± 3.8

30.4 ± 4.4

30.2 ± 5.2

0.303

HGPRest (µM/kg/min)

10.9 ± 0.7

10.8 ± 0.9

11.7 ± 1.2

0.983

HGPInfusion (µM/kg/min)

7.6 ± 2.0

9.3 ± 2.1

10.3 ± 2.9

0.540

% Hepatic Suppression

36 ± 14

37 ± 13

27 ± 11

0.847

Values are means ± SEM. *Significantly different from Rest (p<0.01). a Significantly different
from Control, (p<0.05). b Significantly different from High-CHO, (p<0.05). Rdtot, glucose rate of
disappearance; Rdox, carbohydrate oxidation; Rdnox, non-oxidative glucose disposal. Rest, CIGSIT time points 75, 90 minutes averaged; Infusion, CIG-SIT time points 50, 55, 60 averaged.
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Table 6. Lipid Metabolism

CONTROL

LOW-CHO

HIGH-CHO

P value

FFARest (mM)

0.595 ± 0.042

0.692 ± 0.043a

0.651 ± 0.047

0.046

FFAInfusion (mM)
∆ FFA

0.396 ± 0.036
0.20 ± 0.03

0.455 ± 0.038
0.24 ± 0.04

0.414 ± 0.027
0.24 ± 0.04

0.430
0.490

80.7 ± 9.6

109.8 ± 10.5a

96.7 ± 13.8

0.035

ab

a

FatOxRest (mg/min)
FatOxInfusion (mg/min)
∆ FatOx

35.8 ± 8.1*
45.5 ± 9.5

93.4 ± 10.6
19.42 ± 7.2

72.0 ± 7.4
34.0 ± 8.7

0.001
0.191

RERRest

0.83 ± 0.013

0.76 ± 0.010a

0.80 ± 0.028

0.002

RERInfusion
∆ RER

0.93 ± 0.025*
0.082 ± 0.024

0.81 ± 0.016*ab
0.050 ± 0.016

0.85 ± 0.011*a
0.068 ± 0.020

0.003
0.621

Values are means ± SEM. *Significantly different from Rest (p<0.01). a Significantly different
from Control, (p<0.05). b Significantly different from High-CHO, (p<0.05). FFA, free fatty
acids; FatOx, fat oxidation; RER, respiratory exchange ration; ∆ from rest to infusion during
CIG-SIT. Rest, CIG-SIT time points 75, 90 minutes averaged; Infusion, CIG-SIT time points
50, 55, 60 averaged.
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Figure 1. Experimental Protocol
A. Timeline
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Figure 2. Glucose and Insulin Response to the Post-Exercise Meal
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* Glucose and insulin responses following High-CHO meal were significantly greater
than Low-CHO meal (p<0.001).
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Figure 3. Glucose Uptake Separated into Non-Oxidative and Oxidative
Components
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* Significantly different from CON, p<0.05; † Significantly different from High-CHO, p<0.05.
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Figure 4. Fat Oxidationn
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* Significant compared to control, p<0.05 at rest. † Significant increased compared to
control, p<0.05; †† Significantly increased compared to control and High-CHO, p<0.05.
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Figure 5. The Relationship between Carbohydrate Deficit and Change in Insulin Action
in the Low-CHO Condition.
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Figure 6. The Relationship between Cardiorespiratory Fitness (VO2peak) and
Changes in Insulin Action in the High-CHO Condition.
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1. Informed Consent Document
The effect of meal composition on insulin action following an acute bout of exercise
Investigators: Barry Braun, Ph.D. (413-577-0146)
Todd Hagobian, M.S. (413-545-0331)
Brooke Stephens, M.S. (413-545-0331)
Carrie Sharoff, B.A. (413-545-0331)
Kaila Holtz, B.S. (413-265-3792)
Stuart Chipkin, M.D. (413-545-0089)
Before participating in this research study, your informed consent is required. Please
read each section of the document carefully and initial each page. Sign your name on
the last page if you agree to participate in this study. The investigators have read and
understand the Assurance of Compliance with the Office of Human Research
Protection Regulations for Protection of Human Research Subjects. A copy of this
document can be found at http://www.umass.edu/research/humsub.html. The
University Human Subjects Review Committee has approved this study and the
recruitment of subjects.
Purpose: The prevalence of insulin resistance (impaired uptake of blood sugar
following a meal) and type 2 diabetes in adults in modern Western society has
increased dramatically over the past 50 years. It is estimated that approximately 17%
of adults are insulin resistant and another 5-8% have type 2 diabetes. Studies have
suggested that decreased physical activity has contributed significantly to the
increased prevalence of insulin resistance and type 2 diabetes. A single bout of
exercise, on the other hand, improves the action of insulin (a hormone that lowers
blood sugar) up to 48 hours following the exercise bout. The consumption of a meal or
caloric beverage(s) after exercise may act to counter the effect of exercise. This may
depend upon how much time lapses between the end of exercise and when the meal
is consumed and/or the type or composition of the meal (i.e. fat, protein, and
carbohydrate content). Our lab is currently analyzing the work done on meal timing.
Therefore, the purpose of this study is to determine the effect of meal composition on
insulin action following an acute bout of exercise.
PLEASE NOTE: Participation throughout this study is completely voluntary. You may
withdraw consent at any time in writing or by telephone (413-545-0331) and
discontinue participation in the study without prejudice to you. Please voice any and all
concerns that you have regarding any of the procedures, risks and benefits, your rights
as a subject, or the study itself. Maximizing your safety and comfort is important. If
you have any problems or questions, do not hesitate to contact Dr. Barry Braun (413577-0146, home: 549-0027), Kaila Holtz (413-265-3792, cell) or Dr. Stuart Chipkin
(545-0089). If you would like to discuss your rights as a participant in a research study
or wish to speak with someone not directly involved in the study, you may contact the
Human Subjects Coordinator at humansubjects@ora.umass.edu or (413) 545-3428.
Requirements: You have been asked to participate in this study because you are 1855 years old, NOT pregnant, in overall good health, and do not have any risk factors
for cardiovascular disease, type 2 diabetes, respiratory disease or any other metabolic
disease. In addition, you do not use tobacco products, are not actively trying to lose
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weight, and are not taking anything (pharmaceutical or herbal medications or dietary
supplements) that could interfere with our measurements (for example; metformin,
insulin, ephedra, ginseng, guarana, chromium). If you are uncomfortable having your
blood taken you should not participate in the study.
Briefly, you will undergo a maximal oxygen consumption test (a test to measure
maximal aerobic capacity), body composition measurement, three bouts of endurance
exercise performed on a treadmill or stationary bicycle (whichever you prefer) and four
tests to measure your insulin action to determine how effectively your body uses the
hormone insulin to take sugar out of your blood. You will be given a specific meal to
eat on the day prior to the test to measure insulin action. Most visits will take place in
the Energy Metabolism Laboratory (Room 3, Totman Building) at the University of
Massachusetts Amherst. The DEXA scan will take place at University Health Services.
Parking and directions to the facilities will be made available.
Should you decide to participate in this study, you will be asked to follow the general
testing schedule outlined below.
Overview of Testing Schedule:
You will be asked to report to the laboratory for a total of 10 visits
Visit 1: sign inform consent (approximately 1 hour)
Visit 2: subject qualification session, measurement of body composition, resting energy
expenditure and maximal oxygen consumption test (approximately 3 hours)
Visit 3, 5, 7, and 9: endurance exercise bout, food intake and blood draws
(approximately 3 hours)
Visit 4, 6, 8, and 10: test of insulin action, the morning following the exercise bout or
control trial (approximately 3 hours)
Visit 1: Sign inform consent. You will be provided with a full description of the study
and have the opportunity to ask any questions. At this time you should inform the
investigators of any other studies that you are participating in. Participating in other
studies may exclude you from the study. If you are interested in participating in the
study, you will be familiarized with the exercise procedures and equipment, and an
appointment will be made for a measurement of your maximal aerobic capacity and
body composition.
Visit 2: Subject qualification, body composition, resting energy expenditure and
physical capacity test. You will also be asked to fill out a Physical Activity Readiness
Questionnaire (PAR-Q) and a Health History form that will be interpreted by Dr. Barry
Braun or Brooke Stephens. If you have any food allergies please let us know. Your
aerobic capacity and body composition will be measured (see below).
Body composition: Body composition will be measured using a whole body X-ray called
Dual-Energy X-ray Absorptiometry (DEXA). You will need to wear clothing that
contains no metal (zippers, snaps, etc.) and lie quietly on a padded table while a very
small amount of x-rays are passed through your body and measured by a moving
detector located above you. The procedure takes about 6-11 minutes. The total
amount of x-rays you will be exposed to
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is relatively small (approximately 2 millirems, less than 1/20 of the radiation received
during a single chest-x-ray) and poses no known health risks.
Resting Energy Expenditure: You will rest quietly for 30 minutes either lying down or
reclining in a chair in a darkened room. After 30 minutes, breath samples will be
collected for 20 minutes. You will be wearing a heart rate monitor and breathe into a
mouthpiece and tube. A clip will be placed on your nose so that you can only breathe
through your mouth. This test will provide a measurement of your resting metabolic
rate and will estimate the number of calories you burn over 24 hours.
Maximal oxygen consumption: Maximal oxygen consumption will be determined by
exercising on a stationary bicycle or jogging on a treadmill, whichever you prefer. You
will begin pedaling or walking/jogging at a very easy workload as a warm-up. If you
are on the bike, you will continue to pedal at the same rate while the tension is
increased slightly every 2 minutes. If you are on the treadmill, you will continue to
walk/jog at the same pace and the incline of the treadmill will be increased every 2
minutes. It will become more and more difficult to maintain your pedaling or
walking/jogging rate as the test progresses. The test will be stopped when you feel
you can no longer continue (test usually lasts a total of 8-15 minutes). This test is
physically demanding and you may feel fatigued after the test. The results of this
standard test will be used to set the appropriate level of physical work during the
exercise test. If you are at an increased risk for a cardiac event, are a male over the
age of 40, or a female over the age of 50, you will undergo a medical examination prior
to enrollment in the study and a physician will be present throughout the test of
maximal oxygen consumption.
Visit 3, 5, 7, 9: Endurance exercise, food intake and blood draw: You will report to the
Energy Metabolism Laboratory to complete a bout of exercise on a treadmill or
stationary bicycle (see below for details) or the no exercise control on four separate
occasions. After each exercise bout has ended, you will be provided a meal to eat.
The exercise will be the same each trial, but the composition of the meal (i.e. the
amount of fat, carbohydrate, or protein) will vary. Approximately one hour after
exercise, six blood draws will be taken to measure blood glucose and insulin
concentrations in response to the meal.
Exercise: You will either pedal on the stationary bicycle or jog on a treadmill at a
comfortable pace. You will be wearing a heart rate monitor and breathing into a mouth
piece. The pedaling resistance or treadmill grade will be adjusted during the first 15
minutes of exercise until the rate at which you are working is steady at the desired
value. The exercise should feel slightly difficult but not painful; you will probably feel
fatigued near the end but will not be giving an all-out effort. You will pedal or jog at this
workload for 60-120 minutes. Blood and breath samples will be taken the first 15
minutes during exercise as described above.
Food Intake: All meals following exercise will be provided. The meal will replace all of
the expended calories during exercise. The meal will vary in carbohydrate content and
will be provided in liquid form.
Blood Draws: One hour following the meal, blood will be drawn for plasma glucose and
insulin analysis. A catheter (a small flexible tube) will be inserted into a forearm vein by
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a trained professional for blood sampling. Blood collection will be performed under
sterile conditions by trained individuals. Blood samples of 3ml each will be taken
immediately after the catheter is inserted and at 15, 30, 45, 60 minutes following the
post-exercise meal. There is a risk of some immediate discomfort due to the needle
insertion, as well as bruising that should subside within a week.
Visit 4, 6, 8, and 10: Test of insulin action:
You will be asked to report to the Energy Metabolism Laboratory in the fasting
condition (not having anything to eat or drink (except water) after your exercise bout
and meal the night before your visit).
A catheter (a small flexible tube) will be inserted into a forearm vein by a trained
professional for blood sampling. A second catheter will be placed in a forearm vein of
the opposite arm to allow us to add a glycerol (a part of a fat molecule) and glucose
(sugar) stable isotope directly into your bloodstream. A second catheter will be placed
in a forearm vein of the opposite arm to allow us to add a precise amount of glucose
(sugar) solution in addition to a glycerol and glucose stable isotope solution directly
into your bloodstream.
Both the glucose and glycerol stable isotopes are slightly different forms of the glucose
and glycerol present in your blood. The isotopes allow us to determine how much fat
and carbohydrate (sugar) your muscles are using. They are not radioactive and are
used routinely for measurements in human volunteers. The normal glucose (sugar)
molecule is changed slightly by adding 2 extra particles (neutrons) to make the
glucose used in this study. The glycerol stable isotope is similar to the glucose isotope
but provides an indicator as to the amount of fat you are using rather than
carbohydrate.
While you are resting comfortably, a blood sample (5ml) will be collected from one of
the catheters. Immediately following this blood sample, a small quantity of the glucose
(sugar) in a solution of sterile water will be added through the other catheter. A pump
will then be connected to the catheter and the glucose solution as well as the glucose
and glycerol isotope (a 5th of a teaspoon) will be slowly added through the catheter for
period of 150min (2.5hrs). Blood samples will be taken at 75, 90, 140, 145, and
150min. After 150 minutes the catheters will be removed. You will be free to go as
soon as we are satisfied that you are completely recovered from the procedures.

Risks and Discomforts:
All possible attempts will be made to minimize the risks involved. Trained individuals
will conduct all laboratory procedures with your well being as their first priority. All
procedures will be explained and demonstrated until you are comfortable with the
proposed study. NOTE: Since the catheterization and blood drawing procedures are
a critical element in this study, if you are at all uncomfortable with having your blood
taken you should not participate.
X-ray exposure during DEXA: The total amount of radiation you will be exposed to is
small (approximately 2 millirems, less than 1/20 of the radiation received during a
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single chest-x-ray) and poses no known health risks in non-pregnant women. All
female subjects will be provided with a standard pregnancy home-test kit to minimize
any potential risk
Exercise: During any type of exercise, especially strenuous exercise, there are slight
health risks, along with the possibility of fatigue and muscle soreness. These health
risks are small in people with no prior history of cardiovascular, respiratory or
musculoskeletal disease or injury. Any ordinary fatigue or muscle soreness is
temporary and usually lasts 24-96 hours.
Catheterization: The total amount of blood taken from you during the entire study is
relatively small, 180ml taken over the course of 1.5-2 months. Each experimental
condition (there are four in the study) involves three catheterizations. The first
catheterization is directly after the evening exercise bout and before the post-exercise
meal. This catheter will be removed after the five blood draws (3ml each) following the
post-exercise meal are taken. The second and third catheters will be inserted one after
the other the morning following the exercise bout for the test of insulin action. One
catheter is used for the isotope infusion, the other to draw blood from. The test of
insulin action requires 6 blood draws of 5ml over two and a half hours and both
catheters will be removed immediately following the test. Over the study you will have
12 catheters inserted for blood collection. There are some minor risks involved with
catheters. To minimize these risks, catheters will only be inserted by trained
individuals, using sterile technique at all times. There may be some pain associated
with the needle stick at the moment of insertion, followed by minor discomfort of having
the needle withdrawn and the catheter advanced slightly into the vein. There can be
local infection if the site is not kept clean following the procedure. Some slight bleeding
may also occur following the withdrawal of the catheter. There is the possibility of
bruising of the skin in the area around the catheter that poses no health risk and
should subside within a week. Fainting also occurs in some persons when they sit or
stand following the drawing of blood.
Infusion of isotopes: There is a slight possibility of an anaphylactic reaction (fever, drop
in blood pressure, shortness of breath) to the isotope infusion if the solutions contain
impurities. All solutions are prepared under sterile conditions from compounds that
have been tested for sterility and found to be non-reactive. The risk is very slight. In
performing over 300 of these types of studies over 13 years, the principal investigator
has never observed such a reaction.
Treatment of research-related injuries: In the unlikely event of an injury resulting
directly from participation in this study, investigators will assist you in every way to
ensure you get proper medical attention. The University of Massachusetts does not
have a program for compensating subjects for injury or complications related to human
subjects research but the study personnel will assist you in getting treatment. Dr.
Braun can be reached at 413-577-0146 and Ms. Holtz can be reached at 413-2653792. It also should be understood that by agreeing to participate in this study, you
are not waiving any of your legal rights.
Benefits: You will not gain any direct benefit by participating in this study. You will gain
some specific information about your personal health, including your glucose
tolerance, aerobic capacity, body composition and bone density. If you have any
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questions about this information, you are encouraged to contact your own doctor or
consult the yellow pages for a qualified physician. You will be directly contributing to
our knowledge and assessment of how the combination of exercise and food intake
can be used to decrease the risk for developing Type 2 diabetes and cardiovascular
disease.
Compensation for your time and effort: There is $100 in financial compensation for
your participation in this study. If for any reason you have to withdraw from the study
the compensation for your participation will be pro-rated. You will receive $25 for each
of the experimental conditions you have completed. At the end of the study, we will
also provide information and assist you with any questions you have regarding making
beneficial lifestyle changes in terms of diet and exercise.
Confidentiality: The information obtained in this study will be regarded as privileged
and confidential. If the results of this study are written in a scientific journal or
presented at a scientific meeting your name will not be used. All records will be
maintained in a locked file cabinet accessible only to the investigators in this study. We
may be required to make records available for review by Food and Drug Administration
(FDA) if they request them.
Request for more information: You are encouraged to express any questions,
concerns or doubts regarding the study at any time. The investigators will attempt to
answer all questions to the best of their ability. The investigators will conduct this study
with your best interest, safety, and comfort in mind.
Freedom of Consent: Again, participation throughout this study is completely voluntary.
You may withdraw consent at any time in writing or by telephone (413-545-0331) and
discontinue participation in the study without prejudice to you or your medical care at
UMASS Amherst. Please voice any and all concerns that you have regarding any of
the procedures, risks and benefits, your rights as a subject, or the study itself.
Maximizing your safety and comfort is important. If you have any problems or
questions, do not hesitate to contact. Dr. Barry Braun (413-577-0146, home: 413-5490027), Dr. Stuart Chipkin (413-545-0089, cell 413-433-7418) or Kaila Holtz (265-3792
cell).
has explained to me the purpose
I confirm that
of the research, the study procedures that I will undergo and the possible risks and
discomforts as well as benefits that I may experience. Alternatives to participation in
the study have been discussed. I have read and understood the consent form. I also
understand that cells, blood, or other specimens removed from me during the course
of the study may be valuable for scientific, research or teaching purposes. I authorize
the use of my cells, blood, or other specimens for these purposes. Therefore, I agree
to participate as a subject in this study.
____________________________________________________
___________________
Subject’s Signature
Date
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__________________________________
Name (printed)
____________________________________________________________________
Local Address/Phone Number
Witnessed by:
___________________________________________
Investigator’s Signature
___________________________________________
Investigator’s Name (printed)
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________________
Date

2. Health and Fitness Questionnaire

HEALTH & FITNESS HISTORY
Name: ___________________

E-mail: _________________

Date of Birth: _________
Phone: Home ___________ Work: _____________
Height: _____ Weight: _____
1. Have you ever been diagnosed as having any of the following and if yes, how are
you currently treating the condition?
Y N
High Blood Pressure
Y N

High Cholesterol or High Triglycerides

Y N

Diabetes

Y N

Hypoglycemia (low blood sugar)

Y N

Asthma

2. Does anyone in your family (immediate family including your grandparents) have a
history of cardiovascular disease? (heart attacks, strokes, etc.) Please explain:
3. Does anyone in your family (immediate family including your grandparents) have a
history of type 2 diabetes? Please explain:
4. Have you ever had a glucose tolerance test?
If yes, what were the results?
5. Have you ever had a fasting blood sugar test?
If yes, what were the results?

Y

N

Y N

6. For women:
- Did you have gestational diabetes during any pregnancy?
- Were you ever tested for gestational diabetes?
- How much did your children weigh at birth?
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- For women: are you on hormonal birth control (pill, patch, etc) or estrogen
replacement? Describe in detail:
- What was the date when your last period started? Is your cycle regular?
7. Do you have any neurological problems including fainting, dizziness, headaches or
seizures?
8. Do you have any orthopedic or other health problems that may affect your ability to
perform exercise? If yes, please explain.
9. Are you currently taking any medications, including over-the-counter drugs such as
aspirin, Tylenol or Ibuprofen? Please list:
10. Do you smoke or use smokeless tobacco?
11. Do you drink coffee or other caffeinated beverages? Y
much and how often?

N

What kind, how

12. Please list all vitamins, minerals and herbs and other nutritional supplements
you’re taking:
13 Do you have any food allergies or intolerances? Please describe:
14. How would you describe the type of diet you currently eat? Have you recently
been on any special diets? What kinds of diets have you used to lose weight or lower
cholesterol? Please list and describe:

15. What changes have you made in your diet in the last 6 months?

16. Do you exercise regularly?

What kinds of exercise?

How often?
Please describe how much walking you do on a daily basis:
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17. How does your current exercise and physical activity compare to 6 months ago?
1 year ago?

18. How much did you weigh at birth (if known)?

19. Have you had a physical exam in the past two years?
your assessment of your overall health:

Y N

Please describe

Participant's Signature: _______________________________
Date: __________________
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Meal Composition Study
Subject Summary
Name: Jane Doe
Measurement

You

Normal/Healthy

BMI

21

Less than 25 kg/m2

33.3

Men: Less than 25%
Women: Less than 32%

34.8

Men: Greater than 44 mL/kg/min

93.6

Less than 100 mg/dL

2.33

Score greater than 3.0

82.5

Less than 150 mg/dL

Body fat %

Aerobic Capacity
(mL/kg/min)
Fasting Blood Sugar
(mg/dL)
Insulin Sensitivity
(C-ISI 0-12 Index)
Fasting Triglycerides
(mg/dL)
Energy Expenditure
(Daily) in kcals
Moderate Intensity HR
(65% of VO2peak)

Women: Greater than 39 mL/kg/min

To lose weight the healthy way,
eat 300 to 500kcals less.
When exercising, try and maintain
this heart rate for 30 minutes.

2128
150-165

Metabolic Syndrome Risk Factors Measured in this study:
- Elevated BMI or Body Fat
- Elevated Fasting Glucose
- Low Insulin Sensitivity
- Elevated Triglycerides
The presence of 3 or more Metabolic Syndrome factors is associated with increased
risk for cardiovascular and type 2 diabetes.
For managing both long- and short-term risk, changing your lifestyle can have a big
impact. These lifestyle interventions include*:
•

Weight loss to achieve a desirable weight (BMI less than 25 kg/m2)

•

Increased physical activity, with a goal of at least 30 minutes of moderateintensity activity on most days of the week

•

Healthy eating habits that include reduced intake of saturated fat, trans fat
and cholesterol.

* From the American Heart Association

Attached is some more information about healthy eating and tips to increase your
physical activity by the American Dietetics Association.
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